Á lódáil...
Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
OBJECTIVE: Sodium-glucose co-transporter 2 inhibitors (SGLT2-i) are a novel drug class for the treatment of diabetes. We aimed at describing the maximal benefits and risks associated with SGLT2-i for patients with type 2 diabetes. DESIGN: Systematic review and meta-analysis. DATA SOURCES AND STUDY S...
Na minha lista:
Foilsithe in: | PLoS One |
---|---|
Main Authors: | , , , , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
Public Library of Science
2016
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5106000/ https://ncbi.nlm.nih.gov/pubmed/27835680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0166125 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|